These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 20423719

  • 1. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S, Kalia YN.
    J Control Release; 2010 Aug 03; 145(3):203-9. PubMed ID: 20423719
    [Abstract] [Full Text] [Related]

  • 2. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
    Dubey S, Kalia YN.
    J Control Release; 2011 Jun 30; 152(3):356-62. PubMed ID: 21397646
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
    Dubey S, Perozzo R, Scapozza L, Kalia YN.
    Mol Pharm; 2011 Aug 01; 8(4):1322-31. PubMed ID: 21696184
    [Abstract] [Full Text] [Related]

  • 4. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S, Kalia YN.
    J Control Release; 2014 Jun 10; 183():35-42. PubMed ID: 24657950
    [Abstract] [Full Text] [Related]

  • 5. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
    Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN.
    J Control Release; 2010 Aug 17; 146(1):31-6. PubMed ID: 20678988
    [Abstract] [Full Text] [Related]

  • 6. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN.
    Eur J Pharm Sci; 2010 Mar 18; 39(5):387-93. PubMed ID: 20096354
    [Abstract] [Full Text] [Related]

  • 7. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
    Ita KB, Banga AK.
    Drug Deliv; 2009 Jan 18; 16(1):11-4. PubMed ID: 19555303
    [Abstract] [Full Text] [Related]

  • 8. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T, Pujol-Bello E, Gelfuso GM, de Souza JG, Lopez RF, Kalia YN.
    Eur J Pharm Biopharm; 2014 Feb 18; 86(2):219-26. PubMed ID: 23791718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J, Naik A, Ganem-Rondero A, Quintanar-Guerrero D, Kalia YN.
    Pharm Res; 2007 Jul 18; 24(7):1360-8. PubMed ID: 17457661
    [Abstract] [Full Text] [Related]

  • 11. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN.
    Eur J Pharm Biopharm; 2014 Sep 18; 88(1):56-63. PubMed ID: 24525072
    [Abstract] [Full Text] [Related]

  • 12. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
    Bachhav YG, Heinrich A, Kalia YN.
    Eur J Pharm Biopharm; 2013 Jun 18; 84(2):355-64. PubMed ID: 23207321
    [Abstract] [Full Text] [Related]

  • 13. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
    Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN.
    Mol Pharm; 2013 Nov 04; 10(11):4322-9. PubMed ID: 24028565
    [Abstract] [Full Text] [Related]

  • 14. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM, Corish J, Corrigan OI, Fitzpatrick D.
    Int J Pharm; 2007 Aug 16; 341(1-2):114-24. PubMed ID: 17502130
    [Abstract] [Full Text] [Related]

  • 15. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS, Xiao J, Parsons DL, Babu RJ.
    Drug Dev Ind Pharm; 2012 May 16; 38(5):571-6. PubMed ID: 21980925
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
    Cázares-Delgadillo J, Balaguer-Fernández C, Calatayud-Pascual A, Ganem-Rondero A, Quintanar-Guerrero D, López-Castellano AC, Merino V, Kalia YN.
    Eur J Pharm Biopharm; 2010 Jun 16; 75(2):173-8. PubMed ID: 20332024
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous iontophoretic delivery of CGP69669A, a sialyl Lewis(x) mimetic, in vitro.
    Gratieri T, Wagner B, Kalaria D, Ernst B, Kalia YN.
    Exp Dermatol; 2012 Mar 16; 21(3):226-8. PubMed ID: 22379971
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.